COVID impact on MedTech priorities
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business. Survey respondents work in leadership...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Our Focus Areas
Engagements
- 01CRA opines on irreparable harm at Delaware Chancery CourtIn a matter before the Delaware Chancery Court, CRA was retained by an early-stage pharmaceutical manufacturer whose trade secrets had been misappropriated...View engagement
- 02Transfer pricing planning for the impacts of COVID-19CRA was engaged by a global medical equipment company to analyze, help implement and defend the cross-border allocation of financial and tax impacts of the...View engagement
- 03CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development programIn litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest Insights
Upcoming Events
European Health Forum Gastein
Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.” For more...
Roundtable Discussion: COVID-19 Impact on MedTech
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how...
Recent Events
HTAi 2021 Annual Meeting Manchester: Innovation Through HTA
Anthony Barron is moderating Panel 24: Comprehensive Genomic Profiling (CGP): Can It Ever Bring Enough Value For Routine Clinical Practice? CGP can improve...
The Leukemia & Lymphoma Society’s 2021 New England Man & Woman of the Year
CRA is proud to support the New England region of the LLS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. For...